Annual FCF
-$323.39 M
+$79.40 M+19.71%
December 31, 2023
Summary
- As of February 10, 2025, MOR annual free cash flow is -$323.39 million, with the most recent change of +$79.40 million (+19.71%) on December 31, 2023.
- During the last 3 years, MOR annual FCF has fallen by -$307.32 million (-1913.02%).
Performance
MOR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
N/A
December 31, 2023
Summary
- MOR quarterly free cash flow is not available.
Performance
MOR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
N/A
December 31, 2023
Summary
- MOR TTM free cash flow is not available.
Performance
MOR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
MOR Free Cash Flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +19.7% | - | - |
3 y3 years | -1913.0% | - | - |
5 y5 years | -677.0% | - | - |
MOR Free Cash Flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +85.7% | ||||
5 y | 5-year | +1913.0% | +85.7% | ||||
alltime | all time | -391.4% | +85.7% |
MorphoSys AG Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | -$323.39 M(-19.7%) | - | - |
Jun 2023 | - | -$138.64 M(+80.1%) | -$215.61 M(+24.8%) |
Mar 2023 | - | -$76.97 M(-19.7%) | -$172.82 M(-74.8%) |
Dec 2022 | -$402.79 M(-32.9%) | - | - |
Jun 2022 | - | -$95.86 M(-41.1%) | -$685.58 M(-3.6%) |
Mar 2022 | - | -$162.69 M(-18.0%) | -$711.40 M(+18.5%) |
Dec 2021 | -$600.58 M(+3638.5%) | -$198.47 M(-13.2%) | -$600.58 M(+20.7%) |
Sep 2021 | - | -$228.56 M(+87.8%) | -$497.50 M(+46.2%) |
Jun 2021 | - | -$121.68 M(+134.6%) | -$340.18 M(+13.5%) |
Mar 2021 | - | -$51.87 M(-45.6%) | -$299.64 M(+1765.2%) |
Dec 2020 | -$16.06 M(-83.1%) | -$95.38 M(+33.9%) | -$16.06 M(-150.3%) |
Sep 2020 | - | -$71.25 M(-12.2%) | $31.94 M(-70.1%) |
Jun 2020 | - | -$81.14 M(-135.0%) | $106.93 M(-34.7%) |
Mar 2020 | - | $231.70 M(-589.1%) | $163.64 M(-272.5%) |
Dec 2019 | -$94.86 M(+127.9%) | -$47.38 M(-1365.7%) | -$94.86 M(+22.4%) |
Sep 2019 | - | $3.74 M(-115.3%) | -$77.51 M(+69.4%) |
Jun 2019 | - | -$24.43 M(-8.8%) | -$45.74 M(+26.4%) |
Mar 2019 | - | -$26.80 M(-10.8%) | -$36.18 M(-13.1%) |
Dec 2018 | -$41.62 M(-28.8%) | -$30.03 M(-184.6%) | -$41.62 M(+159.3%) |
Sep 2018 | - | $35.51 M(-338.9%) | -$16.05 M(-77.9%) |
Jun 2018 | - | -$14.86 M(-53.9%) | -$72.58 M(-9.8%) |
Mar 2018 | - | -$32.24 M(+622.9%) | -$80.48 M(+37.7%) |
Dec 2017 | -$58.43 M(+6.6%) | -$4.46 M(-78.8%) | -$58.43 M(-23.3%) |
Sep 2017 | - | -$21.02 M(-7.7%) | -$76.20 M(+10.5%) |
Jun 2017 | - | -$22.76 M(+123.2%) | -$68.99 M(+25.7%) |
Mar 2017 | - | -$10.20 M(-54.1%) | -$54.90 M(+0.2%) |
Dec 2016 | -$54.82 M(+53.0%) | -$22.23 M(+61.1%) | -$54.82 M(-0.5%) |
Sep 2016 | - | -$13.80 M(+59.1%) | -$55.07 M(+11.1%) |
Jun 2016 | - | -$8.67 M(-14.2%) | -$49.55 M(+15.1%) |
Mar 2016 | - | -$10.11 M(-55.0%) | -$43.06 M(+20.2%) |
Dec 2015 | -$35.82 M | -$22.48 M(+171.4%) | -$35.82 M(+18.2%) |
Sep 2015 | - | -$8.28 M(+279.4%) | -$30.30 M(-13.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2015 | - | -$2.18 M(-23.9%) | -$34.89 M(-4.5%) |
Mar 2015 | - | -$2.87 M(-83.1%) | -$36.54 M(-20.8%) |
Dec 2014 | -$46.14 M(-141.6%) | -$16.96 M(+31.7%) | -$46.14 M(+0.6%) |
Sep 2014 | - | -$12.88 M(+236.1%) | -$45.86 M(-146.0%) |
Jun 2014 | - | -$3.83 M(-69.3%) | $99.62 M(+8.5%) |
Mar 2014 | - | -$12.47 M(-25.2%) | $91.80 M(-17.3%) |
Dec 2013 | $110.99 M(<-9900.0%) | -$16.68 M(-112.6%) | $110.99 M(-11.8%) |
Sep 2013 | - | $132.61 M(-1237.8%) | $125.81 M(-4615.3%) |
Jun 2013 | - | -$11.65 M(-273.4%) | -$2.79 M(-168.3%) |
Mar 2013 | - | $6.72 M(-461.0%) | $4.08 M(-708.5%) |
Dec 2012 | -$670.10 K(-102.0%) | -$1.86 M(-146.5%) | -$670.10 K(-95.0%) |
Sep 2012 | - | $4.01 M(-183.7%) | -$13.41 M(-5.5%) |
Jun 2012 | - | -$4.79 M(-342.6%) | -$14.19 M(-170.3%) |
Mar 2012 | - | $1.97 M(-113.5%) | $20.20 M(-38.3%) |
Dec 2011 | $32.72 M(-307.1%) | -$14.60 M(-552.6%) | $32.72 M(-13.0%) |
Sep 2011 | - | $3.23 M(-89.1%) | $37.63 M(+426.6%) |
Jun 2011 | - | $29.60 M(+104.3%) | $7.15 M(-139.7%) |
Mar 2011 | - | $14.49 M(-249.5%) | -$17.98 M(+13.8%) |
Dec 2010 | -$15.80 M(+136.2%) | -$9.69 M(-64.4%) | -$15.80 M(+17.6%) |
Sep 2010 | - | -$27.26 M(-708.7%) | -$13.44 M(-300.7%) |
Jun 2010 | - | $4.48 M(-73.1%) | $6.69 M(-46.6%) |
Mar 2010 | - | $16.67 M(-327.5%) | $12.55 M(-287.6%) |
Dec 2009 | -$6.69 M(-118.4%) | -$7.33 M(+2.8%) | -$6.69 M(-1145.5%) |
Sep 2009 | - | -$7.13 M(-169.0%) | $639.80 K(-91.8%) |
Jun 2009 | - | $10.33 M(-503.0%) | $7.77 M(-403.0%) |
Mar 2009 | - | -$2.56 M | -$2.56 M |
Dec 2008 | $36.35 M(+424.3%) | - | - |
Dec 2007 | $6.93 M(-64.3%) | - | - |
Dec 2006 | $19.40 M(+269.7%) | - | - |
Dec 2005 | $5.25 M(+43.0%) | - | - |
Dec 2004 | $3.67 M(-36.0%) | - | - |
Dec 2003 | $5.73 M(-137.5%) | - | - |
Dec 2002 | -$15.29 M | - | - |
FAQ
- What is MorphoSys AG annual free cash flow?
- What is the all time high annual FCF for MorphoSys AG?
- What is MorphoSys AG annual FCF year-on-year change?
- What is the all time high quarterly FCF for MorphoSys AG?
- What is the all time high TTM FCF for MorphoSys AG?
What is MorphoSys AG annual free cash flow?
The current annual FCF of MOR is -$323.39 M
What is the all time high annual FCF for MorphoSys AG?
MorphoSys AG all-time high annual free cash flow is $110.99 M
What is MorphoSys AG annual FCF year-on-year change?
Over the past year, MOR annual free cash flow has changed by +$79.40 M (+19.71%)
What is the all time high quarterly FCF for MorphoSys AG?
MorphoSys AG all-time high quarterly free cash flow is $231.70 M
What is the all time high TTM FCF for MorphoSys AG?
MorphoSys AG all-time high TTM free cash flow is $163.64 M